The Clorox Company (NYSE:CLX) Receives $155.38 Consensus Target Price from Brokerages

by · The Markets Daily

The Clorox Company (NYSE:CLX – Get Free Report) has been assigned a consensus recommendation of “Reduce” from the fourteen research firms that are covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and one has assigned a buy rating to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $155.38.

Several equities analysts recently weighed in on the stock. Barclays lifted their target price on shares of Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a report on Friday, November 1st. DA Davidson raised their target price on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday. JPMorgan Chase & Co. upped their target price on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research note on Friday, October 11th. Finally, Evercore ISI dropped their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research note on Monday, October 14th.

Get Our Latest Stock Analysis on CLX

Clorox Price Performance

Shares of Clorox stock opened at $157.74 on Thursday. The business’s fifty day moving average price is $164.58 and its 200 day moving average price is $155.17. Clorox has a twelve month low of $127.60 and a twelve month high of $171.37. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The stock has a market capitalization of $19.53 billion, a P/E ratio of 54.96, a PEG ratio of 3.04 and a beta of 0.42.

Clorox (NYSE:CLX – Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.50. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company’s revenue was up 27.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.49 EPS. As a group, research analysts anticipate that Clorox will post 6.85 earnings per share for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.09%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is presently 170.03%.

Institutional Trading of Clorox

Several institutional investors have recently added to or reduced their stakes in the business. Canandaigua National Bank & Trust Co. raised its stake in Clorox by 12.9% during the fourth quarter. Canandaigua National Bank & Trust Co. now owns 9,991 shares of the company’s stock worth $1,623,000 after acquiring an additional 1,145 shares during the period. Central Pacific Bank Trust Division grew its holdings in shares of Clorox by 40.2% during the fourth quarter. Central Pacific Bank Trust Division now owns 785 shares of the company’s stock valued at $127,000 after purchasing an additional 225 shares during the last quarter. GAMMA Investing LLC raised its position in shares of Clorox by 73.5% during the 4th quarter. GAMMA Investing LLC now owns 3,115 shares of the company’s stock worth $506,000 after purchasing an additional 1,320 shares during the period. Versant Capital Management Inc lifted its holdings in shares of Clorox by 45.1% in the 4th quarter. Versant Capital Management Inc now owns 521 shares of the company’s stock worth $85,000 after purchasing an additional 162 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its position in Clorox by 6.9% during the 3rd quarter. Principal Financial Group Inc. now owns 151,257 shares of the company’s stock valued at $24,641,000 after purchasing an additional 9,720 shares during the period. Institutional investors own 78.53% of the company’s stock.

About Clorox

(Get Free Report

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles